BEGIN:VCALENDAR
VERSION:2.0
PRODID:IEEE vTools.Events//EN
CALSCALE:GREGORIAN
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
DTSTART:20230312T030000
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
RRULE:FREQ=YEARLY;BYDAY=2SU;BYMONTH=3
TZNAME:EDT
END:DAYLIGHT
BEGIN:STANDARD
DTSTART:20231105T010000
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
RRULE:FREQ=YEARLY;BYDAY=1SU;BYMONTH=11
TZNAME:EST
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTAMP:20230909T235321Z
UID:087DCD11-D2DB-4AC6-ADCF-0B32BAEC3BE7
DTSTART;TZID=America/New_York:20230816T160000
DTEND;TZID=America/New_York:20230816T170000
DESCRIPTION:Join the IEEE Toronto Instrumentation &amp; Measurement – Robotic
 s &amp; Automation Joint Chapter for a talk on the Diagnostic and Prognostic M
 edical Devices\, presented by Dr. Razieh (Neda) Salahandish.\n\nWednesday\
 , August 16\, 2023 @ 4:00 – 5:00 PM\n\nAbstract: Clinicians are increasi
 ngly interested in employing innovative engineering tools and techniques f
 or early-stage disease diagnosis\, including infectious diseases\, cancers
 \, and brain injury disorders\, to reduce economic\, social\, and health b
 urdens. Integrated biosensing systems\, which combine various scientific d
 isciplines such as biology\, chemistry\, medicine\, electrical engineering
 \, and mechanical engineering\, are viewed as effective approaches to tack
 le the associated medical and health concerns. While conventional laborato
 ry-based testing remains prevalent\, the appeal of routine use of low-cost
  and near-patient diagnostic systems opens up potential avenues for rapid 
 disease screening\, longitudinal medication effectiveness studies\, biomar
 ker discovery\, and prognostics.\n\nIn this research seminar\, Dr. Salahan
 dish delves into the scientific underpinnings and outcomes of her doctoral
  and postdoctoral research\, as well as her ongoing investigations into no
 vel technologies for biomedical devices\, with a specific focus on wearabl
 e diagnostic platforms. This includes the fabrication of compact and multi
 plexed electrochemical biosensing systems\, utilizing screen-printing of c
 hemically engineered nanomaterial inks\, or developing nanocomposite inter
 faces to detect disease-related proteins\, RNAs/DNAs\, and metabolites.\n\
 nAdditionally\, Dr. Salahandish will discuss the integration of biosensing
  strips with microfluidic systems to enable automated on-chip assay perfor
 mance\, as well as the development of impedance-based bi-potentiostats as 
 custom-made handheld readout systems. The combination of these technologie
 s creates a portable quantitative diagnostic platform. Although the clinic
 al applications of electrochemical sensing are still in the early stages o
 f validation\, there are promising research opportunities in utilizing the
 se biosensors for rapid detection of multiple biomarkers\, wearable and in
 -vivo biosensing patches and chips\, and tissue modeling organ-on-a-chip s
 ystems for drug discovery purposes. These advancements hold great potentia
 l in both academic and industrial realms for breakthrough developments in 
 the future.\n\nSpeaker(s): Razieh (Neda) Salahandish\, PhD.\, \n\nVirtual:
  https://events.vtools.ieee.org/m/363735
LOCATION:Virtual: https://events.vtools.ieee.org/m/363735
ORGANIZER:s.sedghizadeh.ca@ieee.org
SEQUENCE:41
SUMMARY:Diagnostic and Prognostic Medical Devices 
URL;VALUE=URI:https://events.vtools.ieee.org/m/363735
X-ALT-DESC:Description: &lt;br /&gt;&lt;p class=&quot;Default&quot;&gt;Join the IEEE Toronto Inst
 rumentation &amp;amp\; Measurement &amp;ndash\; Robotics &amp;amp\; Automation Joint C
 hapter for a talk on the&lt;strong&gt; Diagnostic and Prognostic Medical Devices
 &lt;/strong&gt;\, presented by&amp;nbsp\;&lt;strong&gt;Dr. Razieh (Neda) Salahandish&lt;/stro
 ng&gt;.&lt;/p&gt;\n&lt;p class=&quot;Default&quot;&gt;&amp;nbsp\;&lt;/p&gt;\n&lt;p class=&quot;Default&quot;&gt;&lt;span style=&quot;
 color: #3598db\; font-size: 18pt\;&quot;&gt;&lt;strong&gt;Wednesday\, August 16\, 2023 @
  4:00 &amp;ndash\; 5:00 PM&lt;/strong&gt;&lt;/span&gt;&lt;/p&gt;\n&lt;p class=&quot;Default&quot;&gt;&lt;strong&gt;Abs
 tract:&lt;/strong&gt; Clinicians are increasingly interested in employing innova
 tive engineering tools and techniques for early-stage disease diagnosis\, 
 including infectious diseases\, cancers\, and brain injury disorders\, to 
 reduce economic\, social\, and health burdens. Integrated biosensing syste
 ms\, which combine various scientific disciplines such as biology\, chemis
 try\, medicine\, electrical engineering\, and mechanical engineering\, are
  viewed as effective approaches to tackle the associated medical and healt
 h concerns. While conventional laboratory-based testing remains prevalent\
 , the appeal of routine use of low-cost and near-patient diagnostic system
 s opens up potential avenues for rapid disease screening\, longitudinal me
 dication effectiveness studies\, biomarker discovery\, and prognostics.&lt;/p
 &gt;\n&lt;p class=&quot;Default&quot;&gt;In this research seminar\, &lt;strong&gt;Dr. Salahandish&lt;/
 strong&gt; delves into the scientific underpinnings and outcomes of her docto
 ral and postdoctoral research\, as well as her ongoing investigations into
  novel technologies for biomedical devices\, with a specific focus on wear
 able diagnostic platforms. This includes the fabrication of compact and mu
 ltiplexed electrochemical biosensing systems\, utilizing screen-printing o
 f chemically engineered nanomaterial inks\, or developing nanocomposite in
 terfaces to detect disease-related proteins\, RNAs/DNAs\, and metabolites.
 &lt;/p&gt;\n&lt;p class=&quot;Default&quot;&gt;Additionally\, &lt;strong&gt;Dr. Salahandish&lt;/strong&gt; w
 ill discuss the integration of biosensing strips with microfluidic systems
  to enable automated on-chip assay performance\, as well as the developmen
 t of impedance-based bi-potentiostats as custom-made handheld readout syst
 ems. The combination of these technologies creates a portable quantitative
  diagnostic platform. Although the clinical applications of electrochemica
 l sensing are still in the early stages of validation\, there are promisin
 g research opportunities in utilizing these biosensors for rapid detection
  of multiple biomarkers\, wearable and in-vivo biosensing patches and chip
 s\, and tissue modeling organ-on-a-chip systems for drug discovery purpose
 s. These advancements hold great potential in both academic and industrial
  realms for breakthrough developments in the future.&lt;/p&gt;
END:VEVENT
END:VCALENDAR

